(Total Views: 608)
Posted On: 03/07/2025 8:17:04 PM
Post# of 155813
Not sure if this was posted about the conclusion highlights leronlimab's rapid antiviral effect and its potential as a salvage therapy component for MDR HIV when paired with OBT.
Link
https://pubmed.ncbi.nlm.nih.gov/39972543/
Joseph C Gathe et al. J Acquir Immune Defic Syndr. 2025.
The NCT05271370 extension study (58 participants)
I’ll have to confirm some things but just wanted to post it.
Link
https://pubmed.ncbi.nlm.nih.gov/39972543/
Joseph C Gathe et al. J Acquir Immune Defic Syndr. 2025.
The NCT05271370 extension study (58 participants)
I’ll have to confirm some things but just wanted to post it.
(8)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
